Sara Ciuffa
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Validation of a Duplex Digital PCR Assay for the Quantification of the NK603 Maize Event Across Three dPCR Platforms.
Journal: Foods (Basel, Switzerland)
Published: February 25, 2026
Comparison of two digital PCR platforms for quantification of genetically modified soybean events.
Journal: GM crops & food
Published: November 12, 2025
In-House Validation of Four Duplex Droplet Digital PCR Assays to Quantify GM Soybean Events.
Journal: Foods (Basel, Switzerland)
Published: November 11, 2024
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo.
Journal: Journal of translational medicine
Published: May 13, 2022
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells.
Journal: Current opinion in pharmacology
Published: June 23, 2021
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.
Journal: Scientific reports
Published: May 26, 2021
Targeting the tumor immune microenvironment with "nutraceuticals": From bench to clinical trials.
Journal: Pharmacology & therapeutics
Published: September 30, 2020
Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies.
Journal: International journal of molecular sciences
Published: August 07, 2020
Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-neuT) in Mice with Transplanted Salivary Gland Carcinoma Cells.
Journal: Nutrients
Published: April 01, 2020
Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells.
Journal: Seminars in cancer biology
Published: November 15, 2019
In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101.
Journal: Investigational new drugs
Published: April 25, 2019
Last Updated: 09/26/2026